Literature DB >> 28918466

Mutations in context: implications of BRCA testing in diverse populations.

Gabriela E S Felix1,2,3, Yonglan Zheng1, Olufunmilayo I Olopade4,5.   

Abstract

Cancer is a common non-communicable disease worldwide, although it exhibits differential population trends in incidence and mortality rates. The differences relate to population structure, environmental risk factors as well as health system organization. This article discusses the potential impact of genetic testing on population health, focusing in particular on the mutational spectrum of breast cancer susceptibility genes in diverse populations. We identify the need for improved access to, and increased investment in, comprehensive cancer risk assessment and genetic testing as well as cancer control measures that take into account lifestyle, environmental, and social factors in understudied minority groups.

Entities:  

Keywords:  Breast cancer; Disparity; Genetic testing; Precision medicine

Mesh:

Substances:

Year:  2018        PMID: 28918466      PMCID: PMC5980658          DOI: 10.1007/s10689-017-0038-2

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  147 in total

Review 1.  The impact of next-generation sequencing technology on genetics.

Authors:  Elaine R Mardis
Journal:  Trends Genet       Date:  2008-02-11       Impact factor: 11.639

2.  The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.

Authors:  R B Bar-Sade; A Kruglikova; B Modan; E Gak; G Hirsh-Yechezkel; L Theodor; I Novikov; R Gershoni-Baruch; S Risel; M Z Papa; G Ben-Baruch; E Friedman
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

3.  Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer.

Authors:  Q Gao; S Neuhausen; S Cummings; M Luce; O I Olopade
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.

Authors:  Mary-Claire King; Ephrat Levy-Lahad; Amnon Lahad
Journal:  JAMA       Date:  2014-09-17       Impact factor: 56.272

5.  Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer.

Authors:  Juan Zhang; Renguang Pei; Zhiyuan Pang; Tao Ouyang; Jinfeng Li; Tianfeng Wang; Zhaoqing Fan; Tie Fan; Benyao Lin; Yuntao Xie
Journal:  Breast Cancer Res Treat       Date:  2011-05-26       Impact factor: 4.872

Review 6.  A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change.

Authors:  Bobby Daly; Olufunmilayo I Olopade
Journal:  CA Cancer J Clin       Date:  2015-04-09       Impact factor: 508.702

7.  Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history.

Authors:  Rozany Mucha Dufloth; Sílvia Carvalho; Juliana Karina Heinrich; Júlia Yoriko Shinzato; César Cabello dos Santos; Luiz Carlos Zeferino; Fernando Schmitt
Journal:  Sao Paulo Med J       Date:  2005-07-07       Impact factor: 1.044

8.  Family history, BRCA mutations and breast cancer in Vietnamese women.

Authors:  O M Ginsburg; N V Dinh; T V To; L H Quang; N D Linh; B T H Duong; R Royer; M Llacuachaqui; A Tulman; G Vichodez; S Li; R R Love; S A Narod
Journal:  Clin Genet       Date:  2010-10-18       Impact factor: 4.438

9.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Authors:  M Serrano; G J Hannon; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

10.  Origin and distribution of the BRCA2-8765delAG mutation in breast cancer.

Authors:  Grazia Palomba; Antonio Cossu; Eitan Friedman; Mario Budroni; Antonio Farris; Antonio Contu; Marina Pisano; Paola Baldinu; Maria C Sini; Francesco Tanda; Giuseppe Palmieri
Journal:  BMC Cancer       Date:  2007-07-19       Impact factor: 4.430

View more
  12 in total

1.  Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon.

Authors:  Babatunde Adedokun; Yonglan Zheng; Paul Ndom; Antony Gakwaya; Timothy Makumbi; Alicia Y Zhou; Toshio F Yoshimatsu; Alex Rodriguez; Ravi K Madduri; Ian T Foster; Aminah Sallam; Olufunmilayo I Olopade; Dezheng Huo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-12-23       Impact factor: 4.254

2.  Update on multi-gene panel testing and communication of genetic test results.

Authors:  Sonya Reid; Tuya Pal
Journal:  Breast J       Date:  2020-07-08       Impact factor: 2.431

3.  Strategies to enhance identification of hereditary breast cancer gene carriers.

Authors:  Sonya Reid; Lucy B Spalluto; Tuya Pal
Journal:  Expert Rev Mol Diagn       Date:  2020-09-11       Impact factor: 5.225

4.  Disparities in Genetic Testing and Care among Black women with Hereditary Breast Cancer.

Authors:  Sonya Reid; Sydney Cadiz; Tuya Pal
Journal:  Curr Breast Cancer Rep       Date:  2020-05-19

5.  Analysis of Heterozygous BRCA1 5382ins Founder Mutation in a Cohort of Egyptian Breast Cancer Female Patients Using Pyrosequencing Technique.

Authors:  Salwa H Gomaa Mogahed; Yasser S Hamed; Yassmin E Ibrahim Moursy; Marwa H Mahomoud Saied
Journal:  Asian Pac J Cancer Prev       Date:  2020-02-01

6.  Inherited Breast Cancer in Nigerian Women.

Authors:  Yonglan Zheng; Tom Walsh; Suleyman Gulsuner; Silvia Casadei; Ming K Lee; Temidayo O Ogundiran; Adeyinka Ademola; Adeyinka G Falusi; Clement A Adebamowo; Abideen O Oluwasola; Adewumi Adeoye; Abayomi Odetunde; Chinedum P Babalola; Oladosu A Ojengbede; Stella Odedina; Imaria Anetor; Shengfeng Wang; Dezheng Huo; Toshio F Yoshimatsu; Jing Zhang; Gabriela E S Felix; Mary-Claire King; Olufunmilayo I Olopade
Journal:  J Clin Oncol       Date:  2018-08-21       Impact factor: 50.717

Review 7.  An overview of genetic services delivery for hereditary breast cancer.

Authors:  Sonya Reid; Lucy B Spalluto; Katie Lang; Anne Weidner; Tuya Pal
Journal:  Breast Cancer Res Treat       Date:  2022-01-26       Impact factor: 4.624

8.  Mutational spectrum of breast cancer susceptibility genes among women ascertained in a cancer risk clinic in Northeast Brazil.

Authors:  Gabriela E S Felix; Rodrigo Santa Cruz Guindalini; Yonglan Zheng; Tom Walsh; Elisabeth Sveen; Taisa Manuela Machado Lopes; Juliana Côrtes; Jing Zhang; Polyanna Carôzo; Irlânia Santos; Thaís Ferreira Bonfim; Bernardo Garicochea; Maria Betânia Pereira Toralles; Roberto Meyer; Eduardo Martins Netto; Kiyoko Abe-Sandes; Mary-Claire King; Ivana Lucia de Oliveira Nascimento; Olufunmilayo I Olopade
Journal:  Breast Cancer Res Treat       Date:  2022-03-30       Impact factor: 4.624

9.  Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).

Authors:  Fatima Zahra El Ansari; Farah Jouali; Nabila Marchoudi; Mohcine Mechita Bennani; Naima Nourouti Ghailani; Amina Barakat; Jamal Fekkak
Journal:  BMC Cancer       Date:  2020-08-10       Impact factor: 4.430

Review 10.  Differences in Ovarian and Other Cancers Risks by Population and BRCA Mutation Location.

Authors:  Masayuki Sekine; Koji Nishino; Takayuki Enomoto
Journal:  Genes (Basel)       Date:  2021-07-08       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.